2017 American Transplant Congress » Concurrent Session: PTLD

4:30pm-4:42pm

Inhibition of Multiple Nodes in the PI3K/Akt/mTOR Pathway Synergistically Suppresses Epstein-Barr Virus B Cell Lymphomas.

A. Sang, G. Ivison, X. Qu, C. Esquivel, S. Krams, O. Martinez.

4:42pm-4:54pm

EBV-Specific CD8⁺ T Cells from Pediatric Thoracic vs Abdominal Transplant Recipients Are Shaped Differently by the Chronic EBV Loads with Potential Impact on the Risk of PTLD.

M. Yamada,^1,2 M. Camila,² P. Fadakar,^1,2 K. Hornor,¹ M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.²

4:54pm-5:06pm

The miRNome of EBV+ PTLD is Distinct from EBV+ Infectious Mononucleosis.

Y. Balachandran,¹ V. Kaul,¹ E. Maloney,¹ A. Harris-Arnold,¹ K. Weinberg,² S. Boyd,² D. Bernstein,² C. Esquivel,¹ O. Martinez,¹ S. Krams.¹

5:06pm-5:18pm

Genomic Diversity of Epstein-Barr Virus in Post-Transplant Lymphoproliferative Disorder.

E. Maloney, O. Martinez.

5:18pm-5:30pm

Presence of Anellovirus Nucleic Acid Sequences in Involved Tissue Is Associated with Worse Patient Survival in Post-Transplant Lymphoproliferative Disorder.

V. Dharnidharka, R. Chen, M. Ruzinova, P. Parameswaran, H. O'Gorman, K. Wylie, G. Storch.

5:30pm-5:42pm

Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

B.-H. Shin,¹ S. Ge,¹ J. Mirocha,² D. Thomas,¹ E. Rodriguez,¹ C. Chao,¹ O. Galera,¹ A. Vo,¹ J. Choi,¹ A. Peng,¹ J. Kahwaji,¹ S. Jordan,¹ M. Toyoda.¹

5:42pm-5:54pm

Risk of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients.

E. Engels, P. Mahale, M. Shiels.